TTK Healthcare Ltd

TTK Healthcare Ltd

₹ 1,477 -0.11%
24 May - close price
About

TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1]
It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]

Key Points

Pharmaceuticals Business
The company's pharmaceuticals business includes products for both human and veterinary use:

  • Market Cap 2,087 Cr.
  • Current Price 1,477
  • High / Low 1,744 / 1,101
  • Stock P/E 33.2
  • Book Value 708
  • Dividend Yield 0.68 %
  • ROCE 8.67 %
  • ROE 6.43 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 38.4%
  • Company has been maintaining a healthy dividend payout of 19.6%

Cons

  • Earnings include an other income of Rs.62.6 Cr.
  • Working capital days have increased from 21.5 days to 62.3 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
139 131 150 159 159 193 170 183 180 202 186 184 181
129 125 148 150 154 189 166 174 165 192 176 179 169
Operating Profit 10 6 3 8 5 4 4 8 15 10 10 5 12
OPM % 7% 5% 2% 5% 3% 2% 2% 5% 8% 5% 5% 3% 7%
7 5 15 10 12 606 13 12 12 15 16 16 16
Interest 0 0 0 1 1 3 1 1 1 1 1 0 1
Depreciation 3 3 3 3 3 3 3 3 3 3 3 3 3
Profit before tax 12 8 14 14 12 604 13 16 23 21 22 18 24
Tax % 17% 22% 7% 15% 13% 1% 23% 26% 27% 24% 26% 27% 25%
10 6 13 12 11 601 10 12 17 16 16 13 18
EPS in Rs 7.32 4.25 9.07 8.61 7.52 425.23 7.01 8.49 11.99 11.09 11.33 9.12 12.93
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
382 416 483 519 528 578 628 646 476 599 725 753
362 396 453 478 489 535 578 617 457 577 694 715
Operating Profit 20 20 30 40 38 43 50 28 19 22 31 37
OPM % 5% 5% 6% 8% 7% 7% 8% 4% 4% 4% 4% 5%
7 6 7 6 6 8 8 9 28 42 643 63
Interest 3 3 4 3 3 5 3 3 2 3 5 3
Depreciation 3 3 6 7 12 15 15 14 13 13 13 13
Profit before tax 22 20 26 36 29 30 39 19 32 48 657 84
Tax % 34% 37% 39% 36% 36% 40% 38% 37% -44% 13% 3% 25%
14 12 16 23 19 18 24 12 46 42 640 63
EPS in Rs 18.28 15.95 20.81 29.19 24.13 12.86 17.25 8.72 32.87 29.43 452.72 44.47
Dividend Payout % 22% 25% 22% 17% 21% 39% 29% 34% 18% 34% 2% 22%
Compounded Sales Growth
10 Years: 6%
5 Years: 4%
3 Years: 17%
TTM: 4%
Compounded Profit Growth
10 Years: 18%
5 Years: 21%
3 Years: 16%
TTM: -90%
Stock Price CAGR
10 Years: 10%
5 Years: 17%
3 Years: 35%
1 Year: 17%
Return on Equity
10 Years: 27%
5 Years: 32%
3 Years: 38%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 8 8 8 14 14 14 14 14 14 14
Reserves 90 99 110 128 150 219 237 235 281 316 939 987
22 32 42 38 23 47 29 30 19 22 27 23
89 102 115 128 104 127 136 152 180 207 189 177
Total Liabilities 209 240 275 303 285 407 416 431 494 559 1,170 1,201
43 54 52 106 99 110 98 89 85 80 71 75
CWIP 0 2 46 1 0 1 2 9 0 0 3 1
Investments 1 0 0 10 9 9 13 9 13 15 13 13
165 184 177 185 177 288 304 325 395 463 1,083 1,112
Total Assets 209 240 275 303 285 407 416 431 494 559 1,170 1,201

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
24 13 39 37 18 25 17 20 96 45 -26 -5
-1 -15 -49 -27 5 -22 10 -13 -77 -30 33 28
-2 2 3 -11 -23 -7 -31 -10 -17 -10 -12 -22
Net Cash Flow 22 0 -7 -0 0 -4 -4 -4 2 5 -6 2

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 34 34 34 33 24 35 47 43 46 33 46 42
Inventory Days 52 64 62 66 65 80 77 101 123 102 89 105
Days Payable 55 56 50 53 100 130 101 121 170 134 131 110
Cash Conversion Cycle 31 41 46 46 -11 -16 22 23 -2 1 4 36
Working Capital Days -8 -12 -14 -22 -9 -1 10 13 -18 -15 17 62
ROCE % 21% 17% 20% 23% 18% 15% 15% 8% 6% 8% 10%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.56% 74.56% 74.56% 74.56% 74.56% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57%
2.04% 2.32% 2.35% 2.40% 2.34% 2.37% 2.32% 2.38% 2.40% 1.85% 1.85% 1.85%
2.29% 2.26% 2.23% 2.40% 2.51% 2.22% 2.18% 2.99% 3.27% 3.23% 3.13% 1.14%
21.11% 20.86% 20.85% 20.64% 20.59% 20.84% 20.95% 20.07% 19.76% 20.37% 20.46% 22.45%
No. of Shareholders 15,97417,11516,41615,81715,22814,61714,99515,81816,10915,67216,65117,221

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents